Elevance Health shares are trading higher after B of A Securities upgraded its rating on the stock from Neutral to Buy and raised its price target from $405 to $435.

Benzinga Newsdesk www.benzinga.com Positive 95.3%

Neg 0% Neu 0% Pos 95.3%

Comments

No comments yet. Be the first!